Different Modes of Action of the Imidazoline Compound RX871024 in Pancreatic beta-Cells: Blocking of K+ Channels, Mobilization of Ca2+ from Endoplasmic Reticulum, and Interaction with Exocytotic Machinerya

This publication has 18 references indexed in Scilit:

• Protein phosphorylation and beta-cell function
  Diabetologia, 1994
• The imidazoline site involved in control of insulin secretion: characteristics that distinguish it from I₁‐ and I₂‐sites
  British Journal of Pharmacology, 1994
• Ca2+ and pancreatic B-cell function
  Biochemical Society Transactions, 1994
• Antagonism of the stimulatory effects of efaroxan and glibenclamide in rat pancreatic islets by the imidazoline, RX801080
  British Journal of Pharmacology, 1993
• Staurosporine inhibits protein kinases activated by Ca2+ and cyclic AMP in addition to inhibiting protein kinase C in rat islets of Langerhans
  Molecular and Cellular Endocrinology, 1993
• The α2-adrenoceptor antagonist efaroxan modulates K+ATP channels in insulin-secreting cells
  European Journal of Pharmacology, 1991
• Phentolamine and yohimbine inhibit ATP‐sensitive K+ channels in mouse pancreatic β‐cells
  British Journal of Pharmacology, 1990
• The glucose sensor in HIT cells is the glucose transporter
  FEBS Letters, 1987
• Effect of phentolamine and preperfusion with glucose on insulin release from the isolated perfused pancreas from fasted and fed rats
  Diabetologia, 1975
• ROLE OF ADRENERGIC RECEPTORS IN GLUCOSE-INDUCED INSULIN SECRETION IN MAN
  The Lancet, 1969